Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDAH1 | O94760 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119941 | 0.89 | DDAH1 (0.66) | DDAH1POLBGAANPC1RAB9A | |
| Hydrochloric Acid SCHEMBL5263367 | 0.88 | DDAH1 (0.63) | DDAH1POLBGAANPC1RAB9A | |
| SCHEMBL29437860 | 0.84 | ALDH1A1 (0.60) | DDAH1POLBGAANPC1RAB9A | |
| SCHEMBL75450 | 0.84 | ALDH1A1 (0.60) | DDAH1POLBGAANPC1RAB9A | |
| Fluoride SCHEMBL31379740 | 0.82 | ALDH1A1 (0.58) | DDAH1POLBGAANPC1RAB9A | |
| Pyrrole SCHEMBL5553963 | 0.79 | NPC1 (0.50) | DDAH1POLBGAANPC1RAB9A | |
| Guanidine SCHEMBL4196964 | 0.75 | ALDH1A1 (0.52) | POLBGAANPC1RAB9APKM | |
| SCHEMBL4065464 | 0.75 | POLB (0.72) | DDAH1POLBGAANPC1RAB9A | |
| SCHEMBL231417 | 0.74 | DDAH1 (0.66) | DDAH1POLBGAANPC1RAB9A | |
| SCHEMBL7697312 | 0.74 | GAA (0.53) | DDAH1POLBGAANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130165564-A1 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP AMERICA INC. (US) | 2013-06-27 | — | — | US | claimed |
| EP-2585473-A2 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP America Inc. (US) | 2013-05-01 | — | — | EP | claimed |
| WO-2011163207-A2 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP AMERICA INC. (US) | 2011-12-29 | — | — | WO | claimed |
| EP-2585473-B1 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL IP AMERICA INC (US) | 2015-09-23 | — | — | EP | disclosed |
| US-20130165564-A1 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP AMERICA INC. (US) | 2013-06-27 | — | — | US | disclosed |
| EP-2585473-A2 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP America Inc. (US) | 2013-05-01 | — | — | EP | disclosed |
| WO-2011163207-A2 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP AMERICA INC. (US) | 2011-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165564-A1 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | MTAP, AS3MT, MPHOSPH6 | DDAH1 1049/4885POLB 257/4885GAA 2305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.